Acipimox (3000252813)
From Concept Hub
Concept Properties
| NCID Code | 3000252813 |
|---|---|
| Concept Status | Active (1024) |
| Superceded By | NA |
| Go to edit page: |
|---|
| Definitions |
| Representations |
| + Relationships |
| + Mappings |
Concept Definitions
This concept has the following definitions (descriptions of the meaning of the concept).
| Concept Definition | Language Code | Preferred? |
|---|---|---|
| A niacin derivative used as a hypolipidemic agent; A lipolysis inhibitor; | en | No |
Representations
This concept has the following representations (also known as designations or surface forms).
| Representation | Languge Code | Preferred? |
|---|---|---|
| <protect>Acipimox</protect> | en | Yes |
| 5-methylpyrazine-2-carboxylic acid 4-oxidev | en | No |
| Acipimoxum | La | No |
| C6H6N2O3 | en | No |
| 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid | en | No |
| 5-Methyl-2-pyrazincarbonsaeure-4-oxid | en | No |
| 5-Methylpyrazinecarboxylic acid 4-oxide | en | No |
